|
|
|
|
Vol. 11, Issue 10, 3397-3410, October 2000




¶
Departments of *Biochemistry, Dispersal of epithelial cells is an important aspect of
tumorigenesis, and invasion. Factors such as hepatocyte growth factor induce the breakdown of cell junctions and promote cell spreading and
the dispersal of colonies of epithelial cells, providing a model system
to investigate the biochemical signals that regulate these events.
Multiple signaling proteins are phosphorylated in epithelial cells
during hepatocyte growth factor-induced cell dispersal, including
c-Cbl, a protooncogene docking protein with ubiquitin ligase activity.
We have examined the role of c-Cbl and a transforming variant (70z-Cbl)
in epithelial cell dispersal. We show that the expression of 70z-Cbl in
Madin-Darby canine kidney epithelial cells resulted in the breakdown of
cell-cell contacts and alterations in cell morphology characteristic
of epithelial-mesenchymal transition. Structure-function studies
revealed that the amino-terminal portion of c-Cbl, which corresponds to
the Cbl phosphotyrosine-binding/Src homology domain 2 , is sufficient
to promote the morphological changes in cell shape. Moreover, a point
mutation at Gly-306 abrogates the ability of the Cbl Src homology
domain 2 to induce these morphological changes. Our results identify a
role for Cbl in the regulation of epithelial-mesenchymal transition,
including loss of adherens junctions, cell spreading, and the
initiation of cell dispersal.
Medicine, and
Oncology, and Molecular Oncology Group, Royal Victoria
Hospital, McGill University, Montreal, Quebec H3A 1A1, Canada;
Department of Medicine, Brigham and Women's Hospital,
Harvard Medical School, Boston, Massachusetts; and
§Department of Pathology, The University of Western
Australia, Queen Elizabeth II Medical Center, Nedlands, Western
Australia 6907, Australia
This article has been cited by other articles:
![]() |
H. Y. Zou, Q. Li, J. H. Lee, M. E. Arango, S. R. McDonnell, S. Yamazaki, T. B. Koudriakova, G. Alton, J. J. Cui, P.-P. Kung, et al. An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Cancer Res., May 1, 2007; 67(9): 4408 - 4417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Shattuck, J. K. Miller, M. Laederich, M. Funes, H. Petersen, K. L. Carraway III, and C. Sweeney LRIG1 Is a Novel Negative Regulator of the Met Receptor and Opposes Met and Her2 Synergy Mol. Cell. Biol., March 1, 2007; 27(5): 1934 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Peschard, N. Ishiyama, T. Lin, S. Lipkowitz, and M. Park A Conserved DpYR Motif in the Juxtamembrane Domain of the Met Receptor Family Forms an Atypical c-Cbl/Cbl-b Tyrosine Kinase Binding Domain Binding Site Required for Suppression of Oncogenic Activation J. Biol. Chem., July 9, 2004; 279(28): 29565 - 29571. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Prindull and D. Zipori Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm Blood, April 15, 2004; 103(8): 2892 - 2899. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Christensen, R. Schreck, J. Burrows, P. Kuruganti, E. Chan, P. Le, J. Chen, X. Wang, L. Ruslim, R. Blake, et al. A Selective Small Molecule Inhibitor of c-Met Kinase Inhibits c-Met-Dependent Phenotypes in Vitro and Exhibits Cytoreductive Antitumor Activity in Vivo Cancer Res., November 1, 2003; 63(21): 7345 - 7355. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. I. Taher, E. P. M. Tjin, E. A. Beuling, J. Borst, M. Spaargaren, and S. T. Pals c-Cbl Is Involved in Met Signaling in B Cells and Mediates Hepatocyte Growth Factor-Induced Receptor Ubiquitination J. Immunol., October 1, 2002; 169(7): 3793 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.S. Lindsey and R. M. Brenner Novel hepatocyte growth factor/scatter factor isoform transcripts in the macaque endometrium and placenta Mol. Hum. Reprod., January 1, 2002; 8(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||